Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 3.604
-0.198 (-5.21%)
May 4, 2026, 5:29 PM CET
Cantargia AB Revenue
In the year 2025, Cantargia AB had annual revenue of 316.70M SEK. Cantargia AB had revenue of 8.01M in the quarter ending December 31, 2025.
Revenue
316.70M
Revenue Growth
n/a
P/S Ratio
2.83
Revenue / Employee
14.40M
Employees
22
Market Cap
896.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 316.70M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Saniona AB | 434.40M |
| BioInvent International AB | 217.86M |
| Genovis AB (publ.) | 133.84M |
| Oncopeptides AB | 71.12M |
| Egetis Therapeutics AB | 63.10M |
| Corline Biomedical AB | 8.59M |
| Medivir AB | 8.51M |
| Xspray Pharma AB | 1.10M |
Cantargia AB News
- 2 months ago - Cantargia AB (FRA:7V3) Q4 2025 Earnings Call Highlights: A Year of First-Time Profitability ... - GuruFocus
- 2 months ago - Q4 2025 Cantargia AB Earnings Call Transcript - GuruFocus
- 2 months ago - Cantargia AB Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - Cantargia AB (FRA:7V3) Q3 2025 Earnings Call Highlights: First-Ever Profits and Promising ... - GuruFocus
- 5 months ago - Q3 2025 Cantargia AB Earnings Call Transcript - GuruFocus
- 5 months ago - Cantargia AB Earnings Call Transcript: Q3 2025 - Transcripts
- 6 months ago - Cantargia AB Transcript: Life Science Summit 2025 - Transcripts
- 7 months ago - Cantargia AB Transcript: Investing in Life Science 2025 - Transcripts